These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7564118)

  • 1. Gender-dependent disease severity in autosomal polycystic kidney disease of rats.
    Gretz N; Ceccherini I; Kränzlin B; Klöting I; Devoto M; Rohmeiss P; Hocher B; Waldherr R; Romeo G
    Kidney Int; 1995 Aug; 48(2):496-500. PubMed ID: 7564118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of disease progression in rats with inherited polycystic kidney disease.
    Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
    Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of chronic renal failure in a rat strain with autosomal dominant polycystic kidney disease.
    Gretz N
    Nephron; 1994; 68(4):462-7. PubMed ID: 7870232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
    Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
    Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRD cy/+ rat.
    Bihoreau MT; Ceccherini I; Browne J; Kränzlin B; Romeo G; Lathrop GM; James MR; Gretz N
    Hum Mol Genet; 1997 Apr; 6(4):609-13. PubMed ID: 9097967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
    Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
    Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).
    Uchiyama K; Mochizuki T; Shimada Y; Nishio S; Kataoka H; Mitobe M; Tsuchiya K; Hanaoka K; Ubara Y; Suwabe T; Sekine A; Nutahara K; Tsuruya K; Ishimura E; Nakatani S; Sofue T; Tanaka S; Narita I; Maruyama S; Horie S; Muto S
    Clin Exp Nephrol; 2021 Sep; 25(9):970-980. PubMed ID: 33928479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of renal failure in the Han: SPRD polycystic kidney rat.
    Zeier M; Pohlmeyer G; Deerberg F; Schönherr R; Ritz E
    Nephrol Dial Transplant; 1994; 9(12):1734-9. PubMed ID: 7708256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
    Braun C; Lüdicke C; Rebsch W; Gretz N; van der Woude FJ; Rohmeiss P
    Nephrol Dial Transplant; 1996; 11 Suppl 6():52-7. PubMed ID: 9044329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.
    Kränzlin B; Schieren G; Gretz N
    Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activity of the renal kallikrein-kinin system in autosomal dominant polycystic kidney disease in rats, but not in humans.
    Braun C; Kleemann T; Birck R; Hilgenfeldt U; Riester U; Tschöpe C; van der Woude FJ; Rohmeiss P
    Int Immunopharmacol; 2002 Dec; 2(13-14):1949-56. PubMed ID: 12489808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
    Chapman AB
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1197-204. PubMed ID: 18579674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model.
    Zafar I; Tao Y; Falk S; McFann K; Schrier RW; Edelstein CL
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F854-9. PubMed ID: 17581927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 2002; 113():211-24; discussion 224-6. PubMed ID: 12053711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
    Cowley BD; Ricardo SD; Nagao S; Diamond JR
    Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender hormones and the progression of experimental polycystic kidney disease.
    Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
    Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
    Chonchol M; Gitomer B; Isakova T; Cai X; Salusky I; Pereira R; Abebe K; Torres V; Steinman TI; Grantham JJ; Chapman AB; Schrier RW; Wolf M
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1461-1469. PubMed ID: 28705885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.
    Ravichandran K; Ozkok A; Wang Q; Mullick AE; Edelstein CL
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F349-57. PubMed ID: 25537744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.